PARP inhibitor Pamiparib, Purity ≥98%

Cat. No.: X23-10-ZQ239

PARP inhibitor Pamiparib, Purity ≥98%

Synonym: 1446261-44-4; Pamiparib; BGB-290; Pamiparib [INN]; Pamiparib [USAN]; BGB290; (2R)-14-Fluoro-2-methyl-6,9,10,19-tetrazapentacyclo[14.2.1.02,6.08,18.012,17]nonadeca-1(18),8,12(17),13,15-pentaen-11-one; PARP inhibitor

  • CAS Number: 1446261-44-4
  • Compound CID: 135565554
Product Size
5 mg; 10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
Pamiparib, soluble in DMSO and ethanol and insoluble in water, binds to the PARP enzyme's active site, preventing it from repairing single-strand DNA breaks.
Molecular Weight
298.32
Molecular Formula
C16H15FN4O
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 50 mg/mL (167.61 mM); Water: Insoluble; Ethanol: 38 mg/mL (127.38 mM)
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
Pamiparib can be used to explore its PARP inhibitory effects in cancer research.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.